Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Recro Pharma Inc (REPH)

3.63   -0.24 (-6.2%) 03-05 09:18
Open: 3.81 Pre. Close: 3.87
High: 3.8833 Low: 3.44
Volume: 577,919 Market Cap: 121M
Recro Pharma, Inc. a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products to pharmaceutical market in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was founded in 2007 and is based in Malvern, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.889 - 3.908 3.908 - 3.924
Low: 3.392 - 3.416 3.416 - 3.435
Close: 3.595 - 3.633 3.633 - 3.663

Technical analysis

as of: 2021-03-05 8:51:39 AM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.17     One year: 6.18
Support: Support1: 3.03    Support2: 2.52
Resistance: Resistance1: 4.43    Resistance2: 5.29
Pivot: 4.35
Moving Average: MA(5): 3.74     MA(20): 4.23
MA(100): 2.86     MA(250): 4.12
MACD: MACD(12,26): 0.11     Signal(9): 0.25
Stochastic oscillator: %K(14,3): 21.57     %D(3): 23.05
RSI: RSI(14): 44.86
52-week: High: 9.86  Low: 1.49  Change(%): -63.1
Average Vol(K): 3-Month: 132979  10-Days: 101330

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
REPH has closed above bottom band by 13.4%. Bollinger Bands are 96.9% wider than normal. The large width of the bands suggest high volatility as compared to REPH's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.

Headline News

Tue, 02 Mar 2021
Recro to Present at H.C. Wainwright Global Life Science Conference - GlobeNewswire

Sat, 27 Feb 2021
Recro Pharma, Inc. (REPH) CEO David Enloe on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha

Fri, 26 Feb 2021
Mid-day market update: Nasdaq rises over 100 points; Recro Pharma (REPH Stock) shares plummet - FXStreet

Fri, 26 Feb 2021
Analyst Rating: Will Recro Pharma Inc (REPH) Stock Beat the Market? - InvestorsObserver

Fri, 26 Feb 2021
Recro Pharma, Inc. to Host Earnings Call - Yahoo Finance

Tue, 23 Feb 2021
Recro Announces Amendment to Athyrium Credit Facility - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 24
Shares Float (M) 20
% Held by Insiders 2.40
% Held by Institutions 79.63
Shares Short (K) 974
Shares Short P. Month (K) 966

Stock Financials

EPS -1.083
EPS Est This Year -2.350
EPS Est Next Year -2.590
Book Value (p.s.) -0.640
Profit Margin -34.14
Operating Margin 0.74
Return on Assets (ttm) 0.3
Return on Equity (ttm)
Qtrly Rev. Growth -23.6
Gross Profit (p.s.) 2.041
Sales Per Share 3.140
EBITDA (p.s.) 0.391
Qtrly Earnings Growth
Operating Cash Flow (M) 15
Levered Free Cash Flow (M) 2

Stock Valuations

PE Ratio -3.35
PEG Ratio
Price to Book value -5.67
Price to Sales 1.16
Price to Cash Flow 5.89

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.